1483O Results of a phase I/II combination regimen with ipilimumab (I), nivolumab (N) and trabectedin (T) as first line therapy for advanced leiomyosarcoma

Autor: E. Gordon, W.A. Tellez, D.A. Brigham, C. Valencia, S.P. Chawla, V. Chua-Alcala, A. Moradhkani

Publikováno v: Annals of Oncology. 33:S1225

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::077cf3f4c5278f13c95bb7b5947afd1a
https://doi.org/10.1016/j.annonc.2022.07.1586

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reversible Dysexecutive Syndrome From CSF Overshunting in a Patient With Normal Pressure Hydrocephalus.

Autor: Maneval J; From the Department of Behavioral Neurology (J.M., D.A.), Brigham and Women's Hospital, Boston, MA; and Neuroendovascular Program (A.A.D.), Massachusetts General Hospital, Harvard Medical School, Boston. Jeffrey.Maneval@pennmedicine.upenn.edu., Dmytriw AA; From the Department of Behavioral Neurology (J.M., D.A.), Brigham and Women's Hospital, Boston, MA; and Neuroendovascular Program (A.A.D.), Massachusetts General Hospital, Harvard Medical School, Boston., Acar D; From the Department of Behavioral Neurology (J.M., D.A.), Brigham and Women's Hospital, Boston, MA; and Neuroendovascular Program (A.A.D.), Massachusetts General Hospital, Harvard Medical School, Boston.

Publikováno v: Neurology [Neurology] 2022 Aug 23; Vol. 99 (8), pp. 336-337. Date of Electronic Publication: 2022 Jun 15.